- Home
- LYEL vs RELX Comparison
LYEL vs RELX Comparison
Compare LYEL & RELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LYEL | RELX |
|---|---|---|
| Founded | 2018 | 1903 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 745.5M | 73.3B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | LYEL | RELX |
|---|---|---|
| Price | $30.84 | $40.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | 117.8K | ★ 1.7M |
| Earning Date | 11-12-2025 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.14% |
| EPS Growth | N/A | ★ 3.29 |
| EPS | N/A | ★ 1.42 |
| Revenue | $41,000.00 | ★ $13,062,063,298.00 |
| Revenue This Year | N/A | $6.02 |
| Revenue Next Year | N/A | $6.61 |
| P/E Ratio | ★ N/A | $28.03 |
| Revenue Growth | N/A | ★ 2.48 |
| 52 Week Low | $7.65 | $39.31 |
| 52 Week High | $45.00 | $56.33 |
Technical Indicators
Market Signals| Indicator | LYEL | RELX |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 43.99 |
| Support Level | $32.01 | $40.96 |
| Resistance Level | $45.00 | $41.48 |
| Average True Range (ATR) | 3.42 | 0.35 |
| MACD | -0.65 | 0.15 |
| Stochastic Oscillator | 3.20 | 32.33 |
Price Performance
Historical ComparisonAbout LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About RELX RELX PLC PLC
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.